A Novel Cause of Familial Hypercholesterolemia: PCSK9 Gene Duplication

被引：3
|
作者：
Paquette, Martine [1 ]
Baass, Alexis [1 ,2 ,3 ]
机构：
[1] Montreal Clin Res Inst, Lipids Nutr & Cardiovasc Prevent Clin, 110 Ave Pins Ouest, Montreal, PQ H2W 1R7, Canada
[2] McGill Univ, Div Expt Med, Dept Med, Montreal, PQ, Canada
[3] McGill Univ, Div Med Biochem, Dept Med, Montreal, PQ, Canada
来源：
CANADIAN JOURNAL OF CARDIOLOGY | 2018年 / 34卷 / 10期
关键词：
AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; DENSITY-LIPOPROTEIN RECEPTOR; MUTATIONS;
D O I：
10.1016/j.cjca.2018.08.027
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1259 / 1260
页数：2
相关论文
共 50 条
  • [31] How many familial hypercholesterolemia patients are eligible for PCSK9 inhibition?
    Masana, Luis
    Plana, Nuria
    Perez-Calahorra, Sofia
    Ibarretxe, Daiana
    Lamiquiz-Moneo, Itziar
    Pedro-Botet, Juan
    Suarez-Tembra, Manuel
    Valdivielso, Pedro
    Ortega, Emilio
    Civeira, Fernando
    ATHEROSCLEROSIS, 2017, 262 : 107 - 112
  • [32] PCSK9, a new gene involved in familial hypercholesteremia
    Lambert, G
    Costet, P
    Krempf, M
    Lalanne, F
    M S-MEDECINE SCIENCES, 2004, 20 (12): : 1068 - 1070
  • [33] PCSK9 inhibition in patients with hypercholesterolemia
    Desai, Nihar R.
    Sabatine, Marc S.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2015, 25 (07) : 567 - 574
  • [34] PCSK9: a new target for hypercholesterolemia
    Cariou, B.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 16 - 16
  • [35] PCSK9 and Hypercholesterolemia: Therapeutic Approach
    Obradovic, Milan
    Zaric, Bozidarka
    Sudar-Milovanovic, Emina
    Ilincic, Branislava
    Stokic, Edita
    Perovic, Milan
    Isenovic, Esma R.
    CURRENT DRUG TARGETS, 2018, 19 (09) : 1058 - 1067
  • [36] PCSK9 inhibitors: Novel therapeutic agents for the treatment of hypercholesterolemia
    Verbeek, Rutger
    Stoekenbroek, Robert M.
    Hovingh, G. Kees
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 763 : 38 - 47
  • [37] Targeting PCSK9 for the treatment of hypercholesterolemia
    Hedrick, Joseph A.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (09) : 938 - 946
  • [38] PCSK9 inhibitors for treating hypercholesterolemia
    Pasta, Andrea
    Cremonini, Anna Laura
    Pisciotta, Livia
    Buscaglia, Angelo
    Porto, Italo
    Barra, Fabio
    Ferrero, Simone
    Brunelli, Claudio
    Rosa, Gian Marco
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (03) : 353 - 363
  • [39] PCSK9 Antibodies for the Treatment of Hypercholesterolemia
    Gouni-Berthold, Ioanna
    Berthold, Heiner K.
    NUTRIENTS, 2014, 6 (12): : 5517 - 5533
  • [40] The Molecular Basis of Familial Hypercholesterolemia in Lebanon: Spectrum of LDLR Mutations and Role of PCSK9 as a Modifier Gene
    Abifadel, Marianne
    Rabes, Jean-Pierre
    Jambart, Selim
    Halaby, Georges
    Gannage-Yared, Marie-Helene
    Sarkis, Antoine
    Beaino, Ghada
    Varret, Mathilde
    Salem, Nabiha
    Corbani, Sandra
    Aydenian, Hermine
    Junien, Claudine
    Munnich, Arnold
    Boileau, Catherine
    HUMAN MUTATION, 2009, 30 (07) : E682 - E691
12345